LG Chem (051910) Q3 2025 earnings summary

Executive summary

• Q3 2025 saw consolidated sales of RMB 11.196 trillion (KRW 11,196 bn), operating profit of RMB 680 billion (KRW 680 bn), and net income of RMB 447 billion (KRW 447 bn), marking a return to profitability with an improved operating margin of 6.1% from the previous quarter.

• Profitability was driven by cost reductions, lower raw material prices, and a one-time upfront payment in Life Sciences.

• The business environment remains challenging due to weak global demand, easing of U.S. environmental regulations, and geopolitical uncertainties.

Financial highlights

• Assets at Q3-end were RMB 98.5 trillion, liabilities RMB 52.2 trillion, and capital RMB 46.2 trillion.

• Debt ratio increased year-over-year to 113%.

• Gross margin rose to 21.3% in Q3 2025 from 16.6% in Q2 2025.

• Petrochemical sales were RMB 4.461 trillion with operating profit of RMB 29 billion.

• Advanced Materials sales were RMB 838 billion, operating profit RMB 7 billion, and OP margin 0.9%.

• Life Sciences sales were RMB 375 billion, operating profit RMB 101 billion, boosted by an out-licensing payment.

• Energy Solution sales were RMB 5.7 trillion, operating profit RMB 601 billion, OP margin 10.5%.

• Cash and equivalents at quarter-end were KRW 8,593 bn.

Outlook and guidance

• Continued weak global demand expected in Q4 and into 2026, with profitability likely to drop in Q4 due to scheduled plant turnaround.

• 2026 outlook remains cautious due to ongoing capacity additions in Asia and persistent oversupply, but focus will be on high-value-added products and cost savings.

• Advanced Materials expects demand decline to persist due to policy changes and conservative inventory management.

• New cathode shipments for Toyota to begin next year, with growth momentum expected by 2026.

• Life Sciences foresee lower profitability due to the absence of one-time license-out revenue and higher R&D expenses.